时间：2025-07-22 10:12:37 来源：本站
在医药研发迈向智能化、数字化的浪潮中，技术驱动已成为提升效率与保障质量的关键。
2025年6月，国际去中心化临床试验（DCT）解决方案先锋——信华医药（Xincere），与全球领先的临床试验移动设备定制专家——Inventus，正式达成战略合作。
Embracing Intelligent, Digital-Driven R&D: Xincere and Inventus Announce Strategic Partnership. As the pharmaceutical industry moves toward intelligent, digital-driven research and development, technology has become key to boosting efficiency and ensuring quality. In June 2025, DCT pioneer Xincere and global leader in custom clinical-trial devices Inventus officially entered into a strategic partnership, ushering in a new era of smart clinical-trial equipment.
此次战略合作，正是双方优势的完美契合，聚焦四大核心领域 Four Pillars of Our Partnership：
01 海外尖端设备引进与深度定制化 Deep-Customizing Advanced Overseas Device
信华医药将依托Inventus强大的全球资源网络和顶尖工程能力，引入其高品质的海外研发与生产设备。更为关键的是，Inventus的“深度定制化”基因将在此次合作中充分展现，双方将共同设计开发专用设备解决方案。
Xincere will leverage Inventus’s global resource network and engineering expertise to bring in high-quality, overseas-developed devices. Crucially, Inventus’s DNA of “deep customization” will shine as both companies co-design and develop dedicated clinical-trial hardware tailored to China’s diverse trial scenarios.
02 本土化MDM软件方案赋能研发数据治理 Localizing MDM for Robust Data Governance
面对国内日益严格的医药研发数据规范高要求，双方将共同推进Inventus先进的移动设备管理(MDM)软件解决方案在国内医药研发场景的落地与优化。
In response to China’s ever-tightening regulations on R&D data integrity, the partners will jointly implement and optimize Inventus’s advanced mobile device management (MDM) software in local trial settings—enabling precise control over device lifecycles, patient data, and protocol compliance.
03 全球eSIM连接保障 End-to-End Global eSIM Connectiv
依托Inventus广泛的全球运营商合作网络，双方将为临床试验设备提供内置eSIM解决方案，确保在多中心、多国家环境下实现无缝漫游和稳定数据传输，为试验数据的实时性和完整性保驾护航。
Tapping into Inventus’s extensive partnerships with network operators worldwide, the collaboration will embed eSIM technology in trial devices—guaranteeing seamless roaming and stable data transmission across multiple centers and countries, thereby safeguarding real-time data flow and completeness.
04 共绘未来临床试验智能设备蓝图 Next Generation of Smart Trial Devices
基于对当前国内临床试验设备应用现状，痛点(如设备便携性不足、续航焦虑、数据实时性差、环境适应性弱、管理困难等)以及未来需求的深入交流，信华医药与Inventus将携手探索和定义下一代智能化临床试验设备的理想形态。
Building on an in-depth exchange about current domestic device challenges—portability, battery life, data latency, environmental resilience, and management complexity—Xincere and Inventus will jointly explore and define the ideal form factor for next-generation smart clinical-trial equipment.
此次信华医药与Inventus的强强联手，是基于共同愿景的技术与产业的深度融合。双方将以本次战略合作为起点，持续深化在技术研发、设备优化、数据治理及未来应用场景探索等层面的协同创新，共同推动医药研发向更智能、更高效、更合规的方向加速发展。
This alliance between Xincere and Inventus is a deep fusion of shared vision, technology, and industry expertise. As a starting point, both companies will continue to drive co-innovation in R&D, device optimization, data governance, and emerging trial scenarios—together propelling pharmaceutical R&D toward a smarter, more efficient, and rigorously compliant future.
▮ 信华医药（Xincere）：全球领先的去中心化临床试验(DCT)平台解决方案供应商，专注于开发以患者为中心的远程智能临床试验平台。通过将数字技术与人工智能应用于临床试验，Xincere致力于提升临床试验的可及性、减轻患者负担、提高临床研究质量与效率，并降低药物研发成本。
About Xincere
Xincere is a global frontrunner in decentralized clinical-trial (DCT) platforms, dedicated to building patient-centric, remote-enabled smart trial solutions. By integrating digital technologies and artificial intelligence into clinical research, Xincere enhances trial accessibility, reduces patient burden, improves data quality and operational efficiency, and drives down drug-development costs.
▮ Inventus：专注于临床试验支持的科技型企业，作为全球唯一聚焦于临床研究设备的OEM制造商，提供覆盖全生命周期的一站式智能终端解决方案，涵盖设备定制、远程管理、全球部署与绿色回收。通过结合前沿技术与临床实际需求，Inventus致力于构建安全、高效、可持续的设备交付与管理体系，助力制药企业与CRO加速临床试验进程，提升数据质量，推动创新药物更快惠及患者。
About Inventus
Inventus is the world’s only OEM manufacturer solely devoted to clinical-trial devices, offering a one-stop, end-to-end smart-terminal solution across the entire product lifecycle—device customization, remote management, global eSIM deployment, and green recycling. By marrying cutting-edge technology with real-world trial needs, Inventus creates secure, efficient, and sustainable device delivery and management systems that help pharmaceutical companies and CROs accelerate trials, elevate data integrity, and bring innovative therapies to patients faster.
上一条：信华医药携手JMSS亮相BIO KOREA 2025 深化中韩生物医药国际合作
下一条：没有了！
合作伙伴
